CRISPR Therapeutics AG Annual Return On Assets in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CRISPR Therapeutics AG quarterly/annual Return On Assets history and growth rate from 2017 to 2023.
  • CRISPR Therapeutics AG Return On Assets for the quarter ending June 30, 2024 was -11.7 %, a 36.5% increase year-over-year.
  • CRISPR Therapeutics AG annual Return On Assets for 2023 was -7.02 %, a 73.9% increase from 2022.
  • CRISPR Therapeutics AG annual Return On Assets for 2022 was -26.9 %, a 286% decline from 2021.
  • CRISPR Therapeutics AG annual Return On Assets for 2021 was 14.5 %.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -7.02 +19.9 +73.9% Jan 1, 2023 Dec 31, 2023
2022 -26.9 -41.4 -286% Jan 1, 2022 Dec 31, 2022
2021 14.5 +40.5 Jan 1, 2021 Dec 31, 2021
2020 -26 -35.6 -370% Jan 1, 2020 Dec 31, 2020
2019 9.62 +47.7 Jan 1, 2019 Dec 31, 2019
2018 -38 -14.9 -64.2% Jan 1, 2018 Dec 31, 2018
2017 -23.2 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.